VivoSeq
Other

Lidocaine Infusion

0

Pipeline Programs

11

Active Trials

0

Companies Involved

Lidocaine Infusion is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

36

clinical trials

Completed16 · 44%
Unknown status7 · 19%
Not yet recruiting5 · 14%
Recruiting3 · 8%
Active, not recruiting2 · 6%
Enrolling by invitation1 · 3%
Other2 · 6%

Trial Activity

36 trials

Intraoperative Lidocaine Infusion
Not yet recruiting··Phase 2/3·NCT07150481·90 enrolled
Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds
Not yet recruiting··Phase 4·NCT06792474·44 enrolled
Lidocaine Infusion in Radical Cystectomy
Completed··Phase 2·NCT03047057·57 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)